Genizon Receives $8.5M in Financing from Pfizer, BTF | GenomeWeb
NEW YORK (GenomeWeb News) - Genizon today said it has raised CA$10 million ($8.5 million) in series D equity financing from Pfizer and Dutch venture capital company BTF.
 
Pfizer’s investment is related to a licensing agreement it signed with Genizon in mid-January. At the time, Genizon said that Pfizer had taken an equity stake in the firm, but it did not disclose the amount of the investment.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.